Laparoscopic Sleeve Gastrectomy Short Term Follow up

Status Recruiting

Clinical Trial Summary

Laparoscopic Sleeve Gastrectomy (LSG), Also known as longitudinal or vertical gastrectomy.

LSG was initially considered a first-stage operation in high-risk patients before bilio-pancreatic diversion or Roux-en-Y gastric bypass surgery. However, LSG was subsequently found to be effective as a single procedure for treatment of morbid obesity.LSG functions mainly as a restrictive procedure in which about 75 % of the stomach is removed leaving a narrow gastric tube or sleeve. So, it limits the amount of food that can be eaten at one time via inducing early satiety after eating a small amount of food due to early distension of the fashioned gastric sleeve giving a sense of satiety, consequently losing excess body weight by time.Sleeve gastrectomy may also cause a decrease in appetite by reducing the amount of Ghrelin (hunger hormone) produced by the stomach.

Clinical Trial Description

All patients,males and females with age (20-50 years old) with morbid obesity (BMI ≥ 40 kg/m2 or > 35 kg/m2 associated with co-morbidity) randomly admitted to Assiut University Hospital-General Surgery Department.

Pre-operative: Assessment of; BMI (Body Mass Index), Fasting Blood Glucose level (FBG), Associated Co-morbidities (as hypertensions & sleep apnea).

Operative (During Operation):

All patients undergo LSG by single team work with intra-operative oesophageal bougie 36 french with use of laparoscopic gastro-intestinal anastomosis(GIA) stapler.

Post-operative:

Patients are discharged from the hospital after they can start oral diet.

Post-operative evaluation of:

1. Complications:

1. Early complications: during the first 2 weeks after surgery,which include hemorrhage (intra-luminal or extra-luminal), staple line leak, vomiting and infection (surgical site infection or intra- abdominal abscess formation)

2. Late complications: from 2 weeks to 6 months post-operative, which include stricture of the gastric sleeve, gastro-esophageal reflux disease (GERD) and nutritional deficiencies.

2. Excess weight loss (EWL) by using BMI Follow up of patients at fifteen days, one month, two months, three months and six months after surgery.

3. Assessment of Blood Glucose level during visits.

4. Measurement of blood pressure during visits (if there is associated hypertension). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03465956
Study type	Interventional
Source	Assiut University
Contact
Status	Recruiting
Phase	N/A
Start date	April 2018
Completion date	July 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03657927` - A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients	N/A
Recruiting	`NCT04934826` - Comparison of the Absorption of Hydrolyzed or Intact Proteins in Morbid Obese Patients After the Roux Y Gastric Bypass	N/A
Completed	`NCT03181347` - The Microbiology of Bariatric Surgery	N/A
Completed	`NCT03886870` - Obesity, Lifestyle and Work Intervention	N/A
Active, not recruiting	`NCT04433338` - The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery	N/A
Completed	`NCT03553849` - Utilization of Very Low Calorie Diet in Obese General Surgery Patients	N/A
Completed	`NCT05854875` - Diabetes Remission After RYGBP and RYGBP With Fundus Resection	N/A
Not yet recruiting	`NCT03203161` - Registry on Obesity Surgery in Adolescents
Not yet recruiting	`NCT03601273` - Bariatric Embolization Trial for the Obese Nonsurgical	Phase 1
Recruiting	`NCT02129296` - Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study	Phase 1/Phase 2
Active, not recruiting	`NCT01564732` - Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding	N/A
Completed	`NCT02033265` - Ultrasound-Guided Axillary Brachial Plexus Block: Influence of Obesity
Completed	`NCT01963637` - Gastric Volumetry by Gastric Tomodensitometry With Gas	N/A
Not yet recruiting	`NCT01652105` - Randomized Trial of Preoperative Diets Before Bariatric Surgery	N/A
Completed	`NCT01955993` - Fentanyl Metabolism in Obese Adolescents	N/A
Terminated	`NCT01759550` - Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
Completed	`NCT01149512` - Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program	N/A
Recruiting	`NCT01685177` - Single Anastomosis Duodeno-Ileal Bypass vs Standard Duodenal Switch as a Second Step After Sleeve Gastrectomy in the Super-Morbid Obese Patient	N/A
Completed	`NCT01536197` - Taste Perception Pre and Post Bariatric Surgery	N/A
Completed	`NCT02414893` - Hunger/Satiety's Physiopathologic Study in Morbidly Obese Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.